Fundz
New|Fundz now works inside Claude2 min

AI made execution free. Knowing first is the whole game now.

The advantage goes to whoever is first into the right conversations, most often. Fundz stacks those odds: more of the moments that create demand than anyone else catches, as they happen, matched to who you sell to, with the decision maker to call. Now it answers in Claude too: ask for today’s leads and who to reach, then write the note in the same window. Not a feed. Not a list you rent. A system for being first.

Trusted by

OracleSnowflakeCloudflareLinkedInGoogleSalesforce
4.8/5 on G2· Since 2015

Genetic Signatures to acquire Microba in merger deal

PRIVATESep 22, 2026about 2 hours ago

Acquiring Company

Genetic Signatures

Acquired Company

Microba Life Sciences Limited

SydneyBiotechnologyHealth CareBiotechnologyHealth CareMedicalTherapeutics

Description

Genetic Signatures has agreed to acquire 100 percent of Microba Life Sciences as part of a merger to form a single group. The merger will involve a share exchange ratio of 0.654 Genetic Signatures shares for each Microba share. The combined entity aims to enhance diagnostic offerings and capitalize on potential cost synergies, creating a leader in gastrointestinal diagnostics.

Company Information

Company

Genetic Signatures

Location

Sydney, New South Wales, Australia

About

Genetic Signatures is a molecular diagnostics company specializing in infectious disease diagnostics. They use patented technology to simplify pathogen detection, enabling laboratories to screen for multiple infections in a single test. The company has a growing international presence, supported by global distribution partnerships.

Fundz sees it the moment Genetic Signatures makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Raj
Likely contact at this company
••••••••@••••••••

See Raj's verified email →

Ken
Likely contact at this company
••••••••@••••••••

See Ken's verified email →

Predictive Intelligence
Strategic

ML-powered predictions for Genetic Signatures's next move

Learn about Strategic plan

M&A Insights

Based on deal data
Integration timeline
70% of M&A integrations take 12-24 months to complete
Tech stack consolidation
83% of merged companies consolidate technology vendors within first year
Post-acquisition investment
Companies increase IT spending by 23% on average after acquisitions
Success factor
M&A deals with strong technology integration plans are 2.5x more likely to succeed

Frequently asked

Who acquired Microba Life Sciences Limited?

Microba Life Sciences Limited was acquired by Genetic Signatures, based in Sydney. The deal was reported on September 22, 2026. Genetic Signatures is a molecular diagnostics company specializing in infectious disease diagnostics. Genetic Signatures is privately held and operates in Biotechnology.

When did Genetic Signatures acquire Microba Life Sciences Limited?

Genetic Signatures's acquisition of Microba Life Sciences Limited was reported on September 22, 2026. Genetic Signatures has agreed to acquire 100 percent of Microba Life Sciences as part of a merger to form a single group. The merger will involve a share exchange ratio of 0.654 Genetic Signatures shares for each Microba share. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does Microba Life Sciences Limited do?

Microba Life Sciences is a precision microbiome company driven to improve human health. It is privately held, operating in Biotechnology.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 285,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.